← Leaderboards
Virginia E Pitzer
Yale University
$5,115,971
Attributed
$6,916,847
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $928.5K · FY2015–25$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,916,847 · 2
By mechanism
R01$6,916,847 · 2
Top collaborators
- Daniel Martin Weinberger6 shared
- Joshua Lindsey Warren5 shared
Most similar at Yale University
Same institution · by research overlap
- Leslie M. Rickey$3,483,606
- Susan H Busch$7,489,344
- Anna Christine Rivara$553,114
- Joshua Lindsey Warren$1,470,436
- Caitlin Hansen$360,540
Others in their field
Top investigators on “Statistical Models”
- David Heimbrook · Leidos Biomedical Research, Inc.$412,248,184
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Lawrence Corey · Fred Hutchinson Cancer Center$182,949,292
- Wafaa M. El-Sadr · Columbia University Health Sciences$151,041,573
- Myron S Cohen · Family Health International$146,816,419
Research focus
Statistical ModelsVaccinesVaccinationChildImmunityTransmission ProcessMathematical ModelVaccine EffectivenessIncidenceSurveillance DataBaseHeterogeneityVaccination StrategyNovel VaccinesClinical TrialsUncertaintyNovel StrategiesCost EffectivenessFuturePatternSubunit VaccinesInfantAccountingEpidemiology
Grant awards (16)
Predicting and monitoring variations in the effects of vaccines against RSV$564,281
R01 · FY2025 · AI
Modeling the impact and cost-effectiveness of next-generation rotavirus vaccine strategies in low- and middle-income countries$422,491
R01 · FY2024 · AI · contact PI
Modeling the impact and cost-effectiveness of next-generation rotavirus vaccine strategies in low- and middle-income countries$425,285
R01 · FY2023 · AI · contact PI
Predicting and monitoring variations in the effects of vaccines against RSV$448,083
R01 · FY2022 · AI
Modeling the impact and cost-effectiveness of next-generation rotavirus vaccine strategies in low- and middle-income countries$426,512
R01 · FY2022 · AI · contact PI
Predicting and monitoring variations in the effects of vaccines against RSV$448,083
R01 · FY2021 · AI
Modeling the impact and cost-effectiveness of next-generation rotavirus vaccine strategies in low- and middle-income countries$426,382
R01 · FY2021 · AI · contact PI
Modeling the impact and cost-effectiveness of next-generation rotavirus vaccine strategies in low- and middle-income countries$480,377
R01 · FY2020 · AI · contact PI
Predicting and monitoring variations in the effects of vaccines against RSV$448,083
R01 · FY2020 · AI
Predicting and monitoring variations in the effects of vaccines against RSV$448,083
R01 · FY2019 · AI
Model-guided assessment of rotavirus vaccine impact in developing countries$371,943
R01 · FY2019 · AI · contact PI
Predicting and monitoring variations in the effects of vaccines against RSV$485,771
R01 · FY2018 · AI
Model-guided assessment of rotavirus vaccine impact in developing countries$372,036
R01 · FY2018 · AI · contact PI
Model-guided assessment of rotavirus vaccine impact in developing countries$372,239
R01 · FY2017 · AI · contact PI
Model-guided assessment of rotavirus vaccine impact in developing countries$372,453
R01 · FY2016 · AI · contact PI
Model-guided assessment of rotavirus vaccine impact in developing countries$404,745
R01 · FY2015 · AI · contact PI